Skip to main content
. 2021 Oct 23;7(5Part A):625–635. doi: 10.1016/j.ijwd.2021.10.005

Fig. 5.

Fig 5

(A–C) Progressive skin depigmentation with anti-PD-1 monoclonal antibodies.